No insider purchase over the last 90 days. The latest, by Mukesh Grover, was filed 12 Sept 2023.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended March 2026 · cache
25 of 33 declarations
At Jeena Sikho Lifecare Limited, an Indian healthcare company listed in Bombay and valued at INR 46.0 billion, the Grover family first buys, then sells. In 2023, 30 purchases worth EUR 1.5 million (median EUR 42,512); on July 25, 2023, Manish Grover bought EUR 185,925, after EUR 163,568 on June 12, 2023, and Bhavna Grover EUR 114,462 on July 27, 2023. Between July 25, 2023 and August 21, 2023, 3 filers bought for EUR 385,017. Across the full history, 24 purchase filings are classed as clustered.
The 3 sales of 2024 weigh far more: EUR 20.6 million in all, including EUR 14,807,416 for Manish Grover on December 10, 2024 and EUR 3,926,894 on June 7, 2024, plus EUR 1,834,756 for Bhavna Grover the same day. Purchases are 91% of open-market trades by count.
Of 33 filings from 3 filers, Manish Grover signs 23 (21 purchases, 2 sales), Bhavna Grover 5 and Mukesh Grover 5 (5 purchases). Volume is 30 filings in 2023 and 3 in 2024. Insiders hold 72.5% of the capital. The last filing was published on December 16, 2024.